A new drug that could help reduce damage to the body after a heart attack, stroke or major surgery has been developed by UK scientists.
Tests in mice suggest the compound protects the heart when blood flow is restored suddenly after a period when tissue has been starved of oxygen. MitoSNO has yet to be tested on humans, but could lead to a whole new class of medicines.
The research is published in the journal Nature Medicine.
One of the problems after a heart attack is the damage caused to heart tissue when blood flow is restored suddenly after a prolonged period without oxygen. Blood flowing back into the tissues triggers production of harmful molecules, called free radicals, which are generated inside mitochondria - the powerhouses of the cell.
A US jury has ordered drugmaker Johnson & Johnson to pay $417m to a woman who...
Scrapping Obamacare’s cost-sharing subsidies would increase premiums on the most popular plans by 20 percent next...
Snack company KIND dumped 45,485 pounds of sugar in Times Square Tuesday to spark conversation about...
President Donald Trump has threatened to blow up Obamacare. But his own administration is separately dangling...
